Key result
Thick-strut bioresorbable scaffolds induced higher platelet aggregation numbers than thin-strut designs in small vessels, suggesting bulky stents increase thrombosis risk.
Why the study?
Does strut thickness and vessel caliber affect the hemodynamic thrombosis risk metrics of bioresorbable scaffolds in computational models?
Does strut thickness and vessel caliber affect the hemodynamic thrombosis risk metrics of bioresorbable scaffolds in computational models?
Computational fluid dynamics suggest that bulky stents implanted in small caliber vessels substantially increase thrombosis risk metrics compared to thin-strut designs.
Answers are grounded in this paper and cite their sources.
May increase thrombosis risk with thick-strut scaffolds in small vessels; hypothesis-generating for design optimization.
Bioresorbable scaffolds (BRS) promise to be the treatment of choice for stenosed coronary vessels. But higher thrombosis risk found in current clinical studies limits the expectations. Three hemodynamic metrics are introduced to evaluate the thrombosis risk of coronary stents/scaffolds using transient computational fluid dynamics (CFD). The principal phenomena are platelet activation and effective diffusion (platelet shear number, PSN), convective platelet transport (platelet convection number, PCN) and platelet aggregation (platelet aggregation number, PAN) were taken into consideration. In the present study, two different stent designs (thick-strut vs. thin-strut design) positioned in small- and medium-sized vessels (reference vessel diameter, RVD=2.25 mm vs. 2.70 mm) were analyzed. In both vessel models, the thick-strut design induced higher PSN, PCN and PAN values than the thin-strut design (thick-strut vs. thin-strut: PSN=2.92/2.19 and 0.54/0.30; PCN=3.14/1.15 and 2.08/0.43; PAN: 14.76/8.19 and 20.03/10.18 for RVD=2.25 mm and 2.70 mm). PSN and PCN are increased by the reduction of the vessel size (PSN: RVD=2.25 mm vs. 2.70 mm=5.41 and 7.30; PCN: RVD=2.25 mm vs. 2.70 mm=1.51 and 2.67 for thick-strut and thin-strut designs). The results suggest that bulky stents implanted in small caliber vessels may substantially increase the thrombosis risk. Moreover, sensitivity analyses imply that PSN is mostly influenced by vessel size (lesion-related factor), whereas PCN and PAN sensitively respond to strut-thickness (device-related factor).
No takes yet. Share an insight, caveat, or question.
Stiehm et al. (2018) studied Stenosed coronary vessels. Thick-strut bioresorbable scaffold design vs. Thin-strut bioresorbable scaffold design was evaluated on Hemodynamic metrics of thrombosis risk (platelet shear number [PSN], platelet convection number [PCN], and platelet aggregation number [PAN]). Thick-strut bioresorbable scaffolds induced higher platelet aggregation numbers than thin-strut designs in small vessels, suggesting bulky stents increase thrombosis risk.
Synapse has enriched 10 related papers. Consider them for comparative context: